Clinical trials sponsored by The Children's Hospital of Zhejiang University School of Medicine
10
Recruiting trials
15
Conditions studied
Phase breakdown
Early Phase 1 4Phase 1 4Not applicable 2
Conditions studied
Recruiting trials led by The Children's Hospital of Zhejiang University School of Medicine
- Allogeneic CD19/BCMA CAR-T for B Cell-Related Autoimmune Disease
- Anti-CD19/BCMA CAR-NK Cells in Patients With B Cell Mediated Autoimmune Disease
- CAR T-cell Therapy Targeting CD19 and BCMA in Patients With B Cell Mediated Autoimmune Disease
- CD19/BCMA UCAR-T for B Cell-Related Autoimmune Disease
- Efficacy and Safety of CD19 UCAR T Cells in Refractory Systemic Lupus Erythematosus
- Exploratory Clinical Study on the Safety and Efficacy of Anti- CD19/BCMA CAR-NK Cell Injection for the Treatment of Refractory Pediatric Rheumatic Diseases
- Immune Profiling of Refractory cSLE Exposed to CD3×CD19 BiTE
- Study of BCMA/CD70 CAR-T Therapy for Refractory cSLE
- Study of Ultra-Fast CD19 CAR-T Therapy for Refractory SLE
- The Efficacy of Specific Immunotherapy Guided by Component-Resolved Diagnosis for Dust Mite Allergens in Chinese Pediatric Patients With Rhinitis and/or Asthma
Common questions
How many trials is The Children's Hospital of Zhejiang University School of Medicine recruiting for?
The Children's Hospital of Zhejiang University School of Medicine is the lead sponsor of 10 recruiting trials.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.